• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Dietary supplement bill focuses on consumer safety

Article

A new bill on dietary supplements recently passed by Congress will focus on adverse reactions that consumers suffer from supplements and various over-the-counter drugs, and should help identify those products that are most dangerous. The measure, S. 3546, would require that makers of dietary supplements and over-the-counter drugs inform the U.S. Food and Drug Administration (FDA) when they learn of "serious adverse events" linked to their products. The bill defines serious events as death, life-threatening experience, inpatient hospitalization, disability, birth defect, or medical/surgical intervention.

A new bill on dietary supplements recently passed by Congress will focus on adverse reactions that consumers suffer from supplements and various over-the-counter drugs, and should help identify those products that are most dangerous. The measure, S. 3546, would require that makers of dietary supplements and over-the-counter drugs inform the U.S. Food and Drug Administration (FDA) when they learn of "serious adverse events" linked to their products. The bill defines serious events as death, life-threatening experience, inpatient hospitalization, disability, birth defect, or medical/surgical intervention.

Unlike prescription drugs, dietary supplements are not required to be proven safe and effective before being marketed. Consumers Union has urged Congress to require adequate pre-market safety testing of dietary supplements and to give the FDA more authority to remove dangerous supplements from the market once safety issues arise.

Related Videos
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
Steven Selbst, MD
© 2024 MJH Life Sciences

All rights reserved.